Stock News
Arog Pharmaceuticals Files For U.S. IPO – Arog Pharmaceuticals (Pending:AROG)
Quick Take Arog Pharmaceuticals (AROG) intends to raise gross proceeds of $74.75 million from a U.S. IPO, according to an S-1 registration statement. The firm is developing therapeutics for blood and solid tumor cancer patients. […]